STERIS plc News
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
see moreSTERIS plc Market News
24d
STERIS Stock Rises Amid Institutional Investment and Analyst Revisions
- STERIS stock gains following institutional investment and analyst updates.
28d
STERIS Stock Sees Volatility Amid Analyst Adjustments and Institutional Moves
STERIS stock experiences fluctuations due to analyst revisions and institutional trading activities.
19 Jul at 19:39
STERIS Stock Experiences Decline Amid Industry Developments and Analyst Adjustments
STERIS stock declines amid industry shifts and analyst adjustments.
12 Jul at 19:37
STERIS Stock Faces Challenges Amid Industry Developments and Financial Updates
STERIS stock experiences volatility due to industry shifts and financial results.
07 Jul at 06:33
STERIS Stock Declines Amid Industry Shifts and Financial Updates
STERIS stock dips 2.03% following Medicare's health tech pilot and financial results.
05 May at 14:47
Steris Tariff Headwind Meets Institutional Demand
Steris (STE) recently reported resilient Q3 results while facing tariff-driven margin pressure. Institutional buying and reaffirmed guidance have stabilized the stock despite short-term gross-margin risk tied to elevated tariffs.
21 Apr at 14:47
Steris Poised by Reprocessing Surge, No News Brief
Steris (STE) saw no company-specific announcements this week; industry data shows a sharp acceleration in medical-device reprocessing demand, which could support long-term revenue upside. Analysts remain cautiously positive, with a near-term price target implying roughly 24% upside.